TA
TFG Advisers’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,570
| Closed | -$207K | – | 201 |
|
|
2023
Q3 | $207K | Buy |
3,570
+26
| +0.7% | +$1.51K | 0.1% | 187 |
|
|
2023
Q2 | $227K | Buy |
3,544
+94
| +3% | +$6.01K | 0.1% | 182 |
|
|
2023
Q1 | $239K | Buy |
3,450
+90
| +3% | +$6.24K | 0.12% | 180 |
|
|
2022
Q4 | $242K | Buy |
3,360
+56
| +2% | +$4.03K | 0.12% | 174 |
|
|
2022
Q3 | $235K | Buy |
3,304
+19
| +0.6% | +$1.35K | 0.13% | 166 |
|
|
2022
Q2 | $253K | Buy |
3,285
+16
| +0.5% | +$1.23K | 0.13% | 161 |
|
|
2022
Q1 | $239K | Buy |
+3,269
| New | +$239K | 0.11% | 182 |
|
|
2021
Q3 | – | Sell |
-3,067
| Closed | -$205K | – | 196 |
|
|
2021
Q2 | $205K | Buy |
+3,067
| New | +$205K | 0.1% | 189 |
|
|
2021
Q1 | – | Sell |
-4,166
| Closed | -$258K | – | 190 |
|
|
2020
Q4 | $258K | Buy |
4,166
+72
| +2% | +$4.46K | 0.14% | 157 |
|
|
2020
Q3 | $246K | Buy |
4,094
+5
| +0.1% | +$300 | 0.14% | 149 |
|
|
2020
Q2 | $240K | Buy |
4,089
+26
| +0.6% | +$1.53K | 0.16% | 141 |
|
|
2020
Q1 | $226K | Buy |
4,063
+1,016
| +33% | +$56.5K | 0.18% | 130 |
|
|
2019
Q4 | $195K | Buy |
+3,047
| New | +$195K | 0.11% | 167 |
|